| # | Drug | Count |
|---|---|---|
| 0 | CITALOPRAM | 3 |
| 1 | CITALOPRAM HYDROBROMIDE | 3 |
| 2 | LORAZEPAM | 3 |
| 3 | AMIFAMPRIDINE PHOSPHATE | 1 |
| 4 | BELIMUMAB | 1 |
| 5 | CARBOPLATIN | 1 |
| 6 | ETOPOSIDE | 1 |
| 7 | HYDROXYCHLOROQUINE | 1 |
| 8 | METHOTREXATE | 1 |
| 9 | METHOTREXATE SODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 1 | BELIMUMAB | 1 | 0.0000 |
| 2 | CITALOPRAM | 3 | 0.0000 |
| 3 | LORAZEPAM | 3 | 0.0000 |
| 4 | ETOPOSIDE | 1 | 0.0000 |
| 5 | CARBOPLATIN | 1 | 0.0000 |
| 6 | PREDNISOLONE ORAL SOLUTION | 1 | 0.0000 |
| 7 | METHOTREXATE SODIUM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Serotonin Reuptake Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Benzodiazepine [EPC] | 3 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 1 | 0.0000 |